beti-cel

BREAKING NEWS | Bluebird’s Gene Therapy For β-Thalassaemia Wins US Approval

The green light is “monumental” for both patients and the company itself, Tom Klima, Bluebird’s Chief Commercial Officer, said in an interview. Bluebird has endured its share of “bumps and…

Read More »